Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Arnold

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Transplantation and Cellular Therapy|November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular TherapyC Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Frontiers in Immunology|February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infectionsDana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Journal of Clinical Immunology|April 25, 2026
Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of ImmunityLuana L T N Porto, Dina Yazji, Dana Unninayar, et al.
Blood Advances|January 27, 2026
Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell DyscrasiasSita Bhella, Gerard Agbayani, Katrina Hueniken, et al.
Vaccines|May 25, 2024
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 StudyCecilia T Costiniuk, Terry Lee, Joel Singer, et al.
Clinical & Translational Immunology|March 31, 2022
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccinationKaren Colwill, Yannick Galipeau, Matthew Stuible, et al.
AIDS (London, England)|December 8, 2022
COVID-19 vaccine immunogenicity in people with HIVCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
AIDS (London, England)|August 3, 2023
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in CanadaCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
Medical Image Analysis|September 16, 2023
Multi-site, Multi-domain Airway Tree ModelingMinghui Zhang, Yangqian Wu, Hanxiao Zhang, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Transplantation and Cellular Therapy|November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular TherapyC Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Frontiers in Immunology|February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infectionsDana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Journal of Clinical Immunology|April 25, 2026
Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of ImmunityLuana L T N Porto, Dina Yazji, Dana Unninayar, et al.
Blood Advances|January 27, 2026
Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell DyscrasiasSita Bhella, Gerard Agbayani, Katrina Hueniken, et al.
Vaccines|May 25, 2024
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 StudyCecilia T Costiniuk, Terry Lee, Joel Singer, et al.
Clinical & Translational Immunology|March 31, 2022
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccinationKaren Colwill, Yannick Galipeau, Matthew Stuible, et al.
AIDS (London, England)|December 8, 2022
COVID-19 vaccine immunogenicity in people with HIVCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
AIDS (London, England)|August 3, 2023
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in CanadaCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
Medical Image Analysis|September 16, 2023
Multi-site, Multi-domain Airway Tree ModelingMinghui Zhang, Yangqian Wu, Hanxiao Zhang, et al.
Pageof 7